Patients with gout: an under-recognised group at high risk of COVID-19
- PMID: 33907738
- PMCID: PMC8062083
- DOI: 10.1016/S2665-9913(21)00073-4
Patients with gout: an under-recognised group at high risk of COVID-19
References
-
- Strangfeld A, Schäfer M, Gianfrancesco MA, et al. Factors associated with COVID-19-related death in people with rheumatic diseases: results from the COVID-19 Global Rheumatology Alliance physician-reported registry. Ann Rheum Dis. 2021 doi: 10.1136/annrheumdis-2020-219498. published online Jan 27. - DOI - PMC - PubMed
-
- Landewé RB, Machado PM, Kroon F, et al. EULAR provisional recommendations for the management of rheumatic and musculoskeletal diseases in the context of SARS-CoV-2. Ann Rheum Dis. 2020;79:851–858. - PubMed
-
- Mikuls TR, Johnson SR, Fraenkel L, et al. American College of Rheumatology guidance for the management of rheumatic disease in adult patients during the COVID-19 pandemic: version 3. Arthritis Rheumatol. 2021;73:e1–12. - PubMed
LinkOut - more resources
Full Text Sources
Other Literature Sources
